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Edited by Maurice MontalAbstract HEK293 cells were transfected with cDNAs for
Gb1(W332A) [a mutant Gb1], Gc2, and inward rectiﬁer K+
channels (Kir3.1/Kir3.2). Application of Gb1c2 protein to these
cells activated the K+ channels only slightly. When mu-opioid
receptors and Kir3.1/Kir3.2 were transfected, application of a
mu-opioid agonist induced a Kir3 current. However, co-expres-
sion of Gb1(W332A) suppressed this current. Most likely,
Gb1(W332A) inhibited the action of the endogenous Gb. Such
a dominant negative eﬀect of Gb1(W332A) was also observed
in neuronal Kir3 channels in locus coeruleus. The mutant,
Gb1(W332A) protein, although inactive, retains its ability to
bind Kir3 and prevents the wild type Gb from activating the
channel.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Kir3 channel1. Introduction
The family of G protein-coupled inward rectiﬁer K+ chan-
nels (GIRK; Kir3) plays important roles in regulating cardiac
rate and neuronal excitability [1,2]. An inhibitory neurotrans-
mitter, through its receptor, activates pertussis toxin-sensitive
G proteins, resulting in the dissociation of Gbc from Ga.
The freed Gbc interacts with the Kir3 channel, and causes
channel activation [3–7]. X-ray crystallography reveals that
Gb contains a seven-bladed propeller. These blades form a
torus-like structure, and one of its surfaces constitutes the ma-
jor interaction site with Ga [8,9]. One residue (Trp332) of Gb1,
situated on this surface, proved to be critical for various func-
tions of Gb. A mutant Gb1 subunit at this residue,
Gb1(W332A), is ineﬀective in activating PLCb2 and adenylyl
cyclase II [10,11]. This mutant is also ineﬀective in activating
GIRK channels [12,13]. Here, we report that Gb1(W332A),*Corresponding author. Fax: +1 312 996 1225.
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doi:10.1016/j.febslet.2006.06.016although inactive, retains its ability to bind to the GIRK chan-
nel and prevents the channel from being activated by the wild
type Gbc. Thus, Gb1(W332A) is a dominant negative Gb1.2. Materials and methods
2.1. Cultures of locus coeruleus neurons
Locus coeruleus neurons were dissociated and cultured from 2 to 4
day old postnatal Long-Evans rats (Charles River Breeding Laborato-
ries) as described previously [14]. Rats were anesthetized with ether,
and after the rats became unconscious (coma), the brainstem was re-
moved, immediately followed by decapitation to ensure euthanasia.
This protocol was approved by the Animal Care Committee of the
University of Illinois at Chicago. Brain slices were made, and the locus
coeruleus was identiﬁed under a dissecting microscope and excised.
The excised pieces were dissociated and cultured for 2 weeks.
2.2. Heterologous expression
HEK293 cells were maintained in DMEM supplemented with 10%
FBS, penicillin (100 U/ml), and streptomycin (100 lg/ml). Transient
transfection was carried out by using Eﬀectene (Qiagen). For single
channel recording, the following cDNAs per 6-cm dish were used. In
control experiments, 0.1 lg GFP, 0.04 lg GIRK1, 0.04 lg GIRK2,
and 0.6 lg empty pCMV5 vector were used. To examine the eﬀects
of the mutant Gb1, we included 0.3 lg Gb1 (W332A) and 0.3 lg
Gc2, instead of the empty vector. For whole-cell experiments: 0.1 lg
GFP, 0.5 lg mu-opioid receptor, 0.15 lg GIRK1, 0.15 lg GIRK2,
and 1.0 lg of empty pCMV5 were used. To observe the eﬀect of the
mutant, 0.5 lg Gb1(W332A) and 0.5 lg Gc2 (instead of the empty vec-
tor) were used. One day after the transfection, the cells were re-plated
to 35-mm dishes, which have a collagen-coated well at the center.
Experiments were conducted three days after the transfection. GIRK1
and GIRK2 cDNAs were from the rat. Gb1 cDNA was from the
mouse and Gc2 cDNA was bovine.
Inside-out patches were used for single channel recordings. Unless
otherwise noted, the compositions of the solutions were as follows.
The external (pipette) solution contained (in mM): 155.4 KCl, 2.4
CaCl2, 1.3 MgCl2, 5 HEPES–NaOH, and 0.0005 tetrodotoxin (pH
7.4). The internal solution contained: 141 potassium D-gluconate, 10
NaCl, 0.5 EGTA–KOH, 0.1 CaCl2, 4 MgCl2, 5 HEPES–KOH, 3
Na2-ATP, 0.2 GDP, and pH 7.2. For whole-cell experiments, the exter-
nal solution was (in mM): 140.5 NaCl, 10 KCl, 2.4 CaCl2, 1.3 MgCl2, 5
HEPES–NaOH, 11 D-Glucose, 0.0005 tetrodotoxin, and pH 7.4. The
internal solution was the same as used in single-channel experiments,
except that it contained 0.2 mM GTP instead of GDP.3. Results
3.1. Apparent irreversibility of Gbc action
Once the GIRK channels are activated by Gbc, the channel
activity was not reversed simply by washing away the Gbcblished by Elsevier B.V. All rights reserved.
Fig. 2. Single channels were recorded from locus coeruleus neurons
with inside-out conﬁguration. In record A (control), bathing solution
(volume, 100 to 150 ll) was slowly exchanged with recombinant wild
type Gb1c2 protein (10 nM; 0.5 ml), resulting in vigorous channel
activity (a2). A separate test using two solutions with diﬀerent
osmolarity indicated that roughly 85% of the original solution was
replaced by using this procedure. (B) Channel activity was barely
noticeable at the beginning (b1). The patch was then treated with
Gb1(W332A)c2 (10 nM; 0.5 ml) for 10 min, followed by exchange with
wild type Gb1c2 (10 nM; 0.5 ml). This produced only slight channel
activity (b2). (C) Summary. Mean and S.E.M. of Npo during 5–9 min
from the start of the perfusion of the wild type Gb1c2 are plotted.
Symbol *: P < 0.05 (non-parametric). The experiments described here
were performed using the same methods and during the same period as
in the previous work [12]. Details on the procedures and the results on
other aspects should be consulted with that publication.
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persists by using GIRK channels in locus coeruleus neurons,
which contain mainly GIRK1 and GIRK2 [16]. As shown in
Fig. 1, application of recombinant wild type Gb1c2
(10 nM) induced a robust GIRK activity. Even after washing
out Gb1c2 by the internal solution thoroughly, the channel
activity persisted without a declining tendency for one hour,
when we stopped recording. We observed this kind of irrevers-
ibility lasting for 12–20 min in three additional patches. De-
spite this ﬁrm binding of Gbc to the channel, application of
Gai-GDP, which would sequester Gb, is known to reverse
the GIRK activity [4,17]. The result suggests that Gbc, once
bound to GIRK, would not be detached spontaneously from
the channel for a long time. This characteristic is important
to interpret the dominant negative action of the mutant Gbc.
3.2. Gb(W332A)
Our previous investigations have shown that mutating cer-
tain residues on Gb1 results in impaired ability of activating
GIRK both in primary cultured locus coeruleus neurons [12]
and in the HEK293 expression system [13]. Among them, the
mutant Gb1(W332A) showed a marked impairment in activat-
ing the GIRK channels. We have, therefore, investigated the
characteristics of this mutant Gb1 in more detail.
Single channel activity of native GIRK channels in cultured
locus coeruleus neurons was studied with the inside-out conﬁg-
uration. Upon patch excision, low activity of GIRK was usu-
ally observed. Application of recombinant wild type Gb1c2 to
the patch induced robust channel activity (Fig. 2A). On the
other hand, after the inside-out patch membrane had been
pre-treated with recombinant Gb1(W332A)c2 protein for
10 min, subsequent application of wild type Gb1c2 protein
produced GIRK activity only sparingly (Fig. 2B and C).
We also performed experiments using a heterologous
expression system. In these experiments, transfection with
Gb1(W332A), instead of application of the recombinant
Gb1(W332A) protein, was used. In Fig. 3A (ctr), HEK293
cells were transfected with GIRK1, GIRK2, and GFP cDNAs.
We made an inside-out patch from a GFP positive cell, and ap-
plied the wild type Gb1c2 protein to the patch. This resulted inFig. 1. Application of recombinant Gb1c2 protein activates GIRK
channels in locus coeruleus neurons apparently irreversibly. The
inside-out conﬁguration was used. Each circle represents the mean Npo
for 30 s. Thick horizontal bars indicate the periods of solution
exchanges. First, 10 nM Gb1c2 was applied. After 11 min, the
Gb1c2 was washed away by superfusing 7 ml of the standard
cytoplasmic solution (control) for 200 s (bath volume, 170 ll).
Holding potential: 101 mV.vigorous channel activity (Fig. 3,a2, a3), indicating that trans-
fected GIRK1/GIRK2 channels were activated by the recom-
binant wild type Gb1c2. By contrast, in cells transfected with
Gb1(W332A) and Gc2, application of the wild type recombi-
nant Gb1c2 to the patch activated the channels only slightly
(Fig. 3B and C). A plausible explanation of these results is that
Gb1(W332A), although its capability of activating GIRK is
lost, retains the ability to bind to the GIRK channel, prevent-
ing the wild type Gb1 from activating the channel.
3.3. GIRK activation through mu-opioid receptor
We have transfected HEK 293 cells with GIRK1, GIRK2
and the mu-opioid receptor (MOR). Application of DAMGO
([D-Ala2, N-Me-Phe4, Gly-ol5]-enkephalin), a mu-opioid
receptor agonist, activated an inwardly-rectifying current
(Fig. 4A). This is probably mediated through the endogenous
Gi/o protein coupled to MOR. The endogenous Gbc subunits,
released upon MOR stimulation, would directly activate the
GIRK channels. However, additional transfection of
Gb1(W332A) reduced the DAMGO-induced current increase
by 80% (Fig. 4B and C). This suggests that binding of
Gb1(W332A) to GIRK1/GIRK2 prevented the endogenous
wild type Gbc from binding and activating the channels. These
results are consistent with the idea that Gb(W332A) acts as a
dominant negative Gb.4. Discussion
The two recombinant proteins (wild type and W332A) used
in the present experiments were produced by Sf9 cells and puri-
Fig. 3. Transfection of HEK293 cells with Gb1(W332A) prevents
GIRK activation by wild type recombinant Gb1c2. (A) Control. The
cell was transfected with GIRK1, GIRK2 and GFP. Single channels
were recorded with the inside-out conﬁguration. Holding potential,
91 mV. (a1) Before the application of recombinant wild type Gb1c2.
(a2) After application of the Gb1c2, resulting in a robust GIRK
channel activity. (a3) Time course of GIRK activity (NPo). The thick
horizontal bar represents the time when the recombinant Gb1c2 was
applied and mixed with control bath solution. The ﬁnal concentration
of Gb1c2 was estimated to be 20 nM. (B) Transfected with
Gb1(W332A). (b1) Before the application of wild type Gb1c2 protein.
(b2) Application of the Gb1c2 protein to the bath solution failed to
activate GIRK channels. (b3) Time course of channel activity (NPo).
(C) Summary. Cells were transfected with GIRK1, GIRK2, GFP and
pCMV5 (Ctr) or Gb1(W332A) and Gc2 instead of pCMV5. The
channel activity was expressed as mean and S.E.M. of NPo over 180–
360 s after application of wild type Gb1c2 (12–38 nM). (*): P < 0.05.
Fig. 4. Transfection of HEK293 cells with Gb1(W332A) prevents the
GIRK activation by DAMGO. (A) and (B) Time course of the whole-
cell currents measured at 127 mV. (A) DAMGO (3 lM) induced a
GIRK current increase in cells expressing GIRK1/GIRK2 and MOR.
(B) DAMGO (3 lM) activated GIRK channels only slightly in a cell
expressing, in addition, Gb1(W332A), instead of pCMV5. (C) Sum-
mary showing the eﬀect of expressing Gb1(W332A) on DAMGO-
induced GIRK current increase. Mean with S.E.M. (**): P < 0.01.
DAMGO was applied through a glass capillary by pressure ejection.
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[12]. Moreover, previously, we tested 12 mutant proteins, and
7 out of these 12 mutant proteins showed a lower potency in
GIRK activation, while the rest showed potency similar to that
of the wild type [12]. This indicates that the diﬀerent potency is
not originated from the procedures of making mutant proteins:
the residue mutated is the determining factor for the diﬀerence
in the potency. Out of those 12 mutants, the W332A mutant
has the lowest potency in activating the GIRK. As for the
experiments using cDNA transfection (Figs. 3 and 4), the same
conclusion can be reached from the data in [13].
The residue W332 of Gb, situated on a surface of the Gb
torus, is known to interact with Ga [8,9]. The mutant
Gb1(W332A) is known to show impaired ability to activate
PLCb2 and adenylyl cyclase type II [10,11]. The crystal struc-
ture of phosducin, a regulator of Gbc activity, shows severalinteraction sites with Gb [18]. Among them, a middle helix
of phosducin binds to Gb at W332. Therefore, it was
speculated that the C-terminus a-helix of GIRK might bind
to the W332 residue of Gb [19]. Thus, Gb(W332) seems to play
an important role in transmitting information to and from
other signaling proteins. Interestingly, despite the impairment
of Gb1(W332A) in transmitting signals to eﬀectors, the inter-
action of this mutant Gb1 with Ga seems to be normal as re-
vealed by the pertussis toxin-induced ADP ribosylation [10].
Here, we have found that Gb1(W332A) acts as a dominant
negative Gb subunit for the eﬀector GIRK1/GIRK2
channel. The evidence for this conclusion is as follows: (i) In
locus coeruleus neurons, application of recombinant
Gb1(W332A)c2 protein to inside-out membrane patches pre-
vented the subsequent application of wild type Gb1c2 protein
from activating the channel. (ii) In HEK293 cells, when
Gb1(W332A)c2 was co-expressed with GIRK, the recombi-
nant wild type Gb1c2 was unable to activate GIRK channels
vigorously. (iii) Expression of Gb1 (W332A) in HEK293 cells
inhibited the GIRK channel activation caused by stimulation
of mu-opioid receptor.
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sites of interaction with GIRK [11–13,20]. The present results
indicated that the mutant Gb1(W332A), while showing deﬁ-
ciency in activating GIRK channel, can bind to GIRK,
preventing the action of wild type Gb1 on GIRK. A hypothet-
ical mechanism would be that residue W332 is important for
activating GIRK, while some of other residues that inter-
act with GIRK could be responsible for the ﬁrm binding
to GIRK. More experiments are necessary to elucidate this
mechanism.
Previous reports of dominant negative mutations of G pro-
teins have been limited to the Ga subunit [21–23]. The present
report has, for the ﬁrst time, identiﬁed a dominant negative G
protein b subunit. This mutant Gb1 (W332A) will be a useful
tool for analyzing the signaling pathways involving G proteins.
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